Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

112 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identification of a broad sarbecovirus neutralizing antibody targeting a conserved epitope on the receptor-binding domain.
Wang Y, Zhang Z, Yang M, Xiong X, Yan Q, Cao L, Wei P, Zhang Y, Zhang L, Lv K, Chen J, Liu X, Zhao X, Xiao J, Zhang S, Zhu A, Gan M, Zhang J, Cai R, Zhuo J, Zhang Y, Rao H, Qu B, Zhang Y, Chen L, Dai J, Cheng L, Hu Q, Chen Y, Lv H, So RTY, Peiris M, Zhao J, Liu X, Mok CKP, Wang X, Zhao J. Wang Y, et al. Among authors: mok ckp. Cell Rep. 2024 Jan 23;43(1):113653. doi: 10.1016/j.celrep.2023.113653. Epub 2024 Jan 3. Cell Rep. 2024. PMID: 38175758 Free article.
High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2.
Vanhove B, Duvaux O, Rousse J, Royer PJ, Evanno G, Ciron C, Lheriteau E, Vacher L, Gervois N, Oger R, Jacques Y, Conchon S, Salama A, Duchi R, Lagutina I, Perota A, Delahaut P, Ledure M, Paulus M, So RT, Mok CK, Bruzzone R, Bouillet M, Brouard S, Cozzi E, Galli C, Blanchard D, Bach JM, Soulillou JP. Vanhove B, et al. bioRxiv [Preprint]. 2020 Oct 28:2020.07.25.217158. doi: 10.1101/2020.07.25.217158. bioRxiv. 2020. Update in: Eur J Immunol. 2021 Jun;51(6):1412-1422. doi: 10.1002/eji.202049072. PMID: 34013271 Free PMC article. Updated. Preprint.
Association of nirmatrelvir-ritonavir with post-acute sequelae and mortality among patients who are immunocompromised with COVID-19 in Hong Kong: a retrospective cohort study.
Lin G, Wei Y, Wang H, Boyer C, Jia KM, Hung CT, Jiang X, Li C, Yam CHK, Chow TY, Wang Y, Zhao S, Guo Z, Li K, Yang A, Mok CKP, Hui DSC, Chong KC, Yeoh EK. Lin G, et al. Among authors: mok ckp. Lancet Rheumatol. 2025 Feb;7(2):e108-e117. doi: 10.1016/S2665-9913(24)00224-8. Epub 2024 Nov 8. Lancet Rheumatol. 2025. PMID: 39527967
COVID-19 vaccination modified the effect of nirmatrelvir-ritonavir on post-acute mortality and rehospitalization: a retrospective cohort study.
Wang H, Wei Y, Lin G, Boyer C, Jia KM, Hung CT, Jiang X, Li C, Yam CHK, Chow TY, Wang Y, Zhao S, Guo Z, Li K, Yang A, Mok CKP, Hui DSC, Chong KC, Yeoh EK. Wang H, et al. Among authors: mok ckp. Emerg Microbes Infect. 2024 Dec;13(1):2421397. doi: 10.1080/22221751.2024.2421397. Epub 2024 Nov 4. Emerg Microbes Infect. 2024. PMID: 39497519 Free PMC article.
Determination of T cell response against XBB variants in adults who received either monovalent wild-type inactivated whole virus or mRNA vaccine or bivalent WT/BA.4-5 COVID-19 mRNA vaccine as the additional booster.
Tang YS, Tan CW, Chong KC, Chen C, Sun Y, Yiu K, Ling KC, Chan KKP, Peiris M, Mok CKP, Hui DS. Tang YS, et al. Among authors: mok ckp. Int J Infect Dis. 2024 Dec;149:107271. doi: 10.1016/j.ijid.2024.107271. Epub 2024 Oct 18. Int J Infect Dis. 2024. PMID: 39426493 Free article.
Association of nirmatrelvir-ritonavir with post-acute sequelae and mortality in patients admitted to hospital with COVID-19: a retrospective cohort study.
Wang H, Wei Y, Hung CT, Lin G, Jiang X, Li C, Jia KM, Yam CHK, Chow TY, Ho JY, Wang Y, Zhao S, Guo Z, Li K, Yang A, Mok CKP, Hui DSC, Yeoh EK, Chong KC. Wang H, et al. Among authors: mok ckp. Lancet Infect Dis. 2024 Oct;24(10):1130-1140. doi: 10.1016/S1473-3099(24)00217-2. Epub 2024 May 3. Lancet Infect Dis. 2024. PMID: 38710190
112 results